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Abstract
Background: The tagging strategy enables full-length endogenous proteins in mammalian cells to
be expressed as green fluorescent fusion proteins from their authentic promoters.
Results: We describe improved genetic tools to facilitate protein tagging in mammalian cells based
on a mobile genetic element that harbors an artificial exon encoding a protein tag. Insertion of the
artificial exon within introns of cellular genes results in expression of hybrid proteins consisting of
the tag sequence fused in-frame to sequences of a cellular protein. We have used lentiviral vectors
to stably introduce enhanced green fluorescent protein (EGFP) tags into expressed genes in target
cells. The data obtained indicate that this strategy leads to bona fide tripartite fusion proteins and
that the EGFP tag did not affect the subcellular localization of such proteins.
Conclusion: The tools presented here have the potential for protein discovery, and subsequent
investigation of their subcellular distribution and role(s) under defined physiological conditions, as
well as for protein purification and protein-protein interaction studies.
Background
Technologies for increasingly comprehensive evaluation
of RNA expression in mammalian cells yield qualitative,
quantitative and temporal information about gene activ-
ity at the mRNA level. However, the correlation between
mRNA and protein levels is often times poor because the
rates of degradation of individual mRNAs and proteins
differ [1,2] and because many proteins are modified after,
they have been synthesized, so that one mRNA can give
rise to more than one protein [3]. Thus, new tools are
needed to detect global changes in protein expression pat-
terns and to determine their subcellular localization [4,5].
Improved molecular tools are also needed to detect
changes in protein expression and/or localization during
differentiation and development allowing a detailed
study of protein function at the single cell level.
Fusion of marker proteins such as β-galactosidase (β-Gal)
or EGFP with cellular proteins facilitates detection of such
proteins and provides information about their intracellu-
lar localization and their potential function(s) [6]. Most
EGFP-based protein tagging techniques reported to date
involved fragments of genomic libraries or individual
cDNAs that were fused to the coding region of EGFP.
Fusion proteins were subsequently expressed and their
subcellular localization in target cells determined by
microscopic inspection. Subsequently, the respective
cDNAs or genes were rescued from the cells or tissues,
cloned and sequenced. EGFP-tagged proteins can be
immediately followed in living cells by time-lapse micro-
scopy to determine their cellular dynamics [7]. However,
when tagging proteins N-terminally or C-terminally, con-
sideration must be given to the effect of the reporter
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protein on masking targeting signals contained within the
expressed protein. For example, amino-terminal fusions
of EGFP to target proteins potentially block signal
sequences associated with import into mitochondria or
the endoplasmic reticulum. Another disadvantage of the
strategies described above is that they rely on exogenous
promoters to drive expression of the tagged protein, pos-
sibly leading to higher levels of the tagged protein relative
Protein tagging system for mammalian cells Figure 1
Protein tagging system for mammalian cells. Schematic diagram of the tagging strategy. The strategy involves an artificial exon 
that is delivered into a target cells where it becomes stably associated with the host cell genome. The artificial exon consists of 
a BSD drug resistance gene sequence flanked by 34-bp loxP sites and lacking an ATG codon. An EGFP coding region lacking 
translational start and stop codons was placed in-frame with the BSD coding region. The artificial exon contains a branch point 
sequence, a polypyrimidine-tract sequence, the mandatory AG dinucleotide of the splice acceptor (SA) site and the mandatory 
GT of the splice donor (SD) site. The presence of a stop codon in the BSD cassette generates a fusion protein containing a 
truncated version of an endogenous protein fused to the BSD resistance protein and enables selection of BSD-resistant cell 
clones. Excision of BSD cassette by Cre-mediated recombination leads to the expression of EGFP fused to an endogenous pro-
tein. E1, E2 and E3 refer to cellular exons.
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Lentiviral delivery of protein tag-encoding sequences Figure 2
Lentiviral delivery of protein tag-encoding sequences. The artificial exon sequence was incorporated into the U3 region of the 
lentiviral 3' LTR. During reverse transcription, a duplicated copy of the 3' LTR region replaces the 5' LTR region. Successful 
integration of this construct occurs into an intronic region of a cellular gene. Cre-mediated recombination involves two con-
secutive loxP-to-loxP recombination events and resulting in the excision of vector sequences between the loxP sites present in 
the 5' and 3' LTRs. This leaves behind the EGFP artificial exon as well as the R and U5 regions of viral 3' LTR integrated. ∆GAG, 
5' portion of the gag coding region; RRE, Rev-response element; pSV40, simian virus early promoter; NEO, neomycin phospho-
transferase coding region. Genomic DNA sequences are marked as straight black lines while vector sequences are marked 
orange.
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to its untagged endogenous counterpart. This again may
impact the correct sorting of such proteins.
To bypass these shortcomings, alternative strategies to tag
proteins were developed. Morin et al. [8] have presented a
novel protein trap approach in which full-length endog-
enous proteins were expressed in Drosophila  as EGFP
fusion proteins from their endogenous promoters. They
described a transposable artificial exon encoding an EGFP
reporter. Devoid of initiation and stop codons and
flanked by splice acceptor (SA) and splice donor (SD)
sites, its insertion into an intron resulted in the produc-
tion of a chimeric protein in which EGFP was fused with
the trapped protein to yield a tripartite fusion protein.
Several hundred independent lines were generated and
shown, in the case of known proteins, that the chimera's
subcellular distribution reflected that of the unmodified
endogenous protein. Furthermore, the use of EGFP
allowed a dynamic study of this distribution in live tis-
sues. Jarvik et al. [9] have tested a similar approach in
mammalian cells. Several hundred mouse NIH 3T3 cell
clones expressing EGFP from Moloney murine leukemia
virus (MLV)-based protein tagging vectors were isolated
and some 60 of them analyzed. The cellular location of
the tagged proteins analyzed corresponded with those of
the untagged counterparts, indicating that the EGFP tag
did not affect the subcellular sorting of the tagged pro-
teins. Protein tagging approaches involving small epitope
tags have also been described [10-12]. The usefulness of
this approach in the context of mammalian cells has
recently been established [13].
A shortcoming of the EGFP-based tagging strategy
reported by Jarvik et al. [9] is that the MLV vectors tend to
preferentially integrate within transcriptional start regions
[14]. This may lead to a biased distribution of tags within
protein coding regions. In this communication, we
describe a system that overcomes this shortcoming by
using lentiviral vectors to stably introduce EGFP in mam-
malian cells. The system also employs a removable drug
resistance marker that allows for selection of insertion
events into expressed genes.
Results
Design of improved protein tagging strategies
The protein tagging strategy is outlined in Figure 1. A drug
resistance marker (blasticidin resistance gene, BSD) lack-
ing a translation initiation codon and harboring two con-
secutive stop codons allows selection of cells expressing
fused proteins by drug selection. To facilitate subsequent
excision of the drug resistance marker by Cre recombinase
[15], loxP sites were placed 5' and 3' of the BSD gene.
Upon providing BSD-positive cells with Cre recombinase,
the BSD resistance gene is deleted. This leaves behind an
EGFP-encoding region, ultimately resulting in a tripartite
fusion protein consisting of EGFP flanked by sequences of
the tagged cellular protein (Figure 1).
Protein tagging in human osteosarcoma cells
The usefulness of the method was tested in human oste-
osarcoma (HOS) cells. HOS cells were transduced with a
modified lentiviral vector [16] bearing the artificial exon
in the long terminal repeat (LTR) sequence (Figure 2). A
total of 105 cells were transduced and then subjected to
BSD selection (5 µg/ml) for two weeks resulting in a total
of 300 BSD-resistant cell clones. Finally, seventy clones
were isolated and subsequently transduced with a Cre
recombinase-encoding lentiviral vector (NL-Cre). All sev-
enty clones were subjected to FACS analysis. Six of the
clones analyzed exhibited a significant increase in the per-
centage of EGFP-positive cells upon transduction with the
NL-Cre vector encoding Cre recombinase as judged by
flow cytometry (Figure 3) indicating that excision of BSD
sequences and concomitant activation of EGFP expression
had taken place.
Analysis of cell clones bearing EGFP-tagged proteins by flow cytometry Figure 3
Analysis of cell clones bearing EGFP-tagged proteins by flow cytometry. The panel shows FACS profiles from BSD-resistant cell 
clones before (gray) and after (green) transduction with a Cre-encoding lentiviral vector. Numbers 1 through 6 indicate indi-
vidual clones.
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Analysis of tagged proteins by confocal microscopy
Clones that exhibited significant EGFP fluorescence were
then subjected to confocal microscopy to investigate the
subcellular localization of EGFP fusion proteins. As
shown in Figure 4, EGFP expression was detected in differ-
ent subcellular compartments. For example, two of the
clones analyzed displayed nuclear staining with EGFP
accumulation in the nucleolus and nucleoplasm respec-
tively, while four of the clones exhibited cytoplasmic
staining.
Identification of tagged proteins
To identify the tagged proteins, RNA was prepared from
cell clones and then subjected to Rapid Amplification of
cDNAs ends (RACE). The PCR products that were
obtained following nested 3' and 5' RACE were sequenced
and analyzed by BLAST (Table 1). In all cases, the subcel-
lular localization of the EGFP-tagged proteins agreed with
the reported subcellular localization of the untagged pro-
teins indicating that the tag sequence had no adverse
effects as far as the subcellular localization of the proteins
analyzed is concerned. For example, the Ras-GTPase-acti-
vating protein-binding protein G3BP is ubiquitously dis-
tributed in the cytoplasm of cells and participates in cell
signaling [17]. The nucleophosmin/B23 protein is a
nucleolar phosphoprotein that changes its localization
depending on the stage of the cell cycle and growth condi-
tions [18]. Kinectin/KTN1 binds to the motor protein
kinesin and participates in cellular transport mediated by
microtubules. This protein is distributed throughout the
Analysis of cell clones bearing EGFP-tagged proteins by confocal microscopy Figure 4
Analysis of cell clones bearing EGFP-tagged proteins by confocal microscopy. The panels show the subcellular localization of 
the corresponding tagged proteins. Images were taken using confocal microscopy without (clones 1, 3, 5 and 6) and with 
deconvolution (clones 2 and 4). Numbers 1 to 6 correspond to clones displayed in Figure 3.
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cytoplasm. The Bcl-2-associated transcription factor/BTF
is found in the nucleus in dot like structures and its trans-
location depends on apoptotic signals [19]. ST13 is an
adaptor protein that mediates the association of the heat
shock proteins HSP70 and HSP90 [20], while G3BP2 cor-
responds to the cytoplasmic Ras_GTPase activating pro-
tein SH3 domain-binding protein 2 [21].
Analysis of sites of proviral integration
Figure 5 shows the distribution of the tagging cassette
among the various cell clones analyzed. In all cases, the
tagging cassette had integrated either centrally or toward
the 3' end of the gene sequence.
Functional analysis of tagged proteins
In order to directly confirm that tagged proteins retained
their physiological properties, we investigated a HOS cell
clone expressing a B23/EGFP fusion protein. A Western
blot analysis of extracts prepared from cells expressing the
B23/EGFP fusion protein revealed a band around 67 kDa
after probing with anti-EGFP antibody (Figure 6A). This
finding is consistent with the view that a full-length ver-
Table 1: Examples of tagged proteins.
Clones 
number
Protein name Localization Accession number 
[GeneBank:]
Site of EGFP tag 
insertion
1 Ras_GTPase activating protein SH3 domain-binding protein (G3BP) cytoplasm AAH06997 -E8b
2 Nucleophosmin/B23 nucleolus NP_954654 E9-E10a
3 Kinectin1/KTN1(kinesin receptor) cytoplasm/membrane NP_891556 -E14b
4 Bcl-2-associated transcription factor (BTF) nucleus NP_055554 E6-E7a
5 Ras_GTPase activating protein SH3 domain-binding protein 2 (G3BP2) cytoplasm NP_036429 E7-E8a
6 Suppression of tumorigenicity 13/ST13 cytoplasm AAH52982 -E5b
aSite of EGFP tag insertion was determined using 5' and 3' RACE; E: Exon
bSite of EGFP tag insertion was determined using 3' RACE
Schematic representation of insertion sites of the artificial exon Figure 5
Schematic representation of insertion sites of the artificial exon. Sites of insertion were identified using 5' and/or 3' RACE fol-
lowed by DNA sequencing. Green triangles represent the artificial exon. Red rectangles represent genomic exons, and blue 
rectangles represent genomic untranslated exons. The exons and introns arrangements were obtained from Human Genomic 
databases through NCBI.
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sion of B23 fused to EGFP was present in such extracts.
B23 was previously shown to dissociate from nucleoli of
cells after treatments with various anticancer drugs includ-
ing daunomycin, actinomycin D, camptothecin, and toy-
ocamycin [22]. To investigate whether B23/EGFP retained
these properties, cells were treated with actinomycin D for
4 h at 37°C. Exposure to this drug provoked translocation
of the B23/EGFP fusion protein from nucleoli to the
nucleoplasm (Figure 6B). This shows that the fusion pro-
tein retained its translocation properties.
Discussion
An attractive feature of the protein tagging method
described in this study is that it is independent of anti-
body probes and allows for direct visualization of tagged
proteins by confocal microscopy. This is in contrast to a
recently described protein trapping method [13] involv-
ing oncogenic retroviral vectors encoding a myc epitope
tag [11]. This method includes fixation and antibody labe-
ling steps and is more cumbersome and ultimately limited
to in vitro applications.
Lentiviral vector-mediated delivery of artificial exons for
protein tagging provides a number of advantages over the
traditional approaches involving oncoretroviral vectors
[9,13]. In contrast to oncogenic retroviral vectors, lentivi-
ral vectors can transduce dividing and non-dividing cells
[23,24] and they appear to integrate preferentially into
transcriptional units [14,25-27]. The preference for
expressed genes for lentiviral vector integration is an
attractive feature in the context of protein tagging
strategies.
In our strategy, EGFP was used for tagging endogenous
proteins and subsequent subcellular protein localization
studies. However, insertion of a bulky EGFP moiety into
cellular proteins may interfere with their native structure,
thus leading to changes in their subcellular localization,
stability and function. A report published by Jarvik et al.
[9] clearly documented the usefulness of EGFP as a marker
for protein tagging. These authors isolated more than 300
EGFP-expressing cell lines and more than 60 of them were
analyzed in detail. The abundance and cellular location of
the tagged proteins analyzed mirrored that of the
untagged counterpart. Our data support this view.
However, it remains to be determined on a case-by-case
basis whether the tagged protein retains its biological
activity.
Analysis of clone bearing B23/EGFP fusion Figure 6
Analysis of clone bearing B23/EGFP fusion. A. Western blot analysis was performed as described in Methods section. Panel a: 
Extract from mock-transduced cells; Panel b: Extract from cells expressing a B23/EGFP fusion protein. B. Localization of B23/
EGFP fusion protein after treatment with actinomycin D. Left panels: Control cells untreated. Right panels: Cells treated with 
0.01 µg/ml of actinomycin D for 4 h at 37°C. After treatment, cells were washed twice with PBS, fixed for 5 min with formal-
dehyde, stained for 5 min with DAPI (0.8 µg/ml) and then washed once with PBS. Images were then taken using confocal micro-
scopy with deconvolution.
A. B.
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Our method takes advantage of an initial enrichment step
using BSD selection to enrich for cell clones expressing
tagged cellular proteins. A subsequent Cre recombinase-
mediated excision step removes all the vector sequences
except for some 330 base pairs derived from the R and U5
regions of the vector LTR. A related selection/excision
strategy for protein trapping events was described by
Sineshchekova et al. [13]. In their strategy, the retroviral
genome was retained. However, the presence of the
complete vector genome could potentially affect the cor-
rect expression of the endogenous gene into which the
vector genome has integrated.
Conclusion
Genome-wide protein tagging approaches have previ-
ously been implemented in Drosophila [8] and in the yeast
Saccharomyces cerevisiae [28-31]. Tagged yeast strains have
provided an unprecedented view of the yeast proteome in
terms of expression levels of defined proteins and their
subcellular localization and they have allowed investigat-
ing the dynamics of protein abundance and movement in
cells in response to chemical and genetic influences. Sim-
ilar applications are emerging in mammalian cells [9,13].
We expect the improved protein tagging strategy described
in this communication to strengthen such approaches.
We also believe that the tagging strategy described in this
report will allow for the application of approaches akin to
tandem affinity purification tagging [32] that can be used
to purify and analyze protein complexes. Another poten-
tial application of our technique would involve the use of
fluorescence resonance energy transfer (FRET) to detect
protein-protein interactions between fluorescent tags on
interacting proteins [33].
Methods
Plasmid constructs
Plasmid pNL-5.1 was constructed as follows. A mini-exon
bearing SD and SA sequences, a myc tag encoding
sequence [11] and EcoRI and PstI sites, flanked by 34-bp
loxP sites was generated by overlap extension [34] and
subcloned between the KpnI and XhoI sites present in
pLITMUS 28 (New England BioLabs). A BSD resistance
gene cassette without an ATG codon but containing two
consecutive stop codons was generated by PCR using
pcDNA6 /V5-His A (Invitrogen) and primers BSD-F-EcoRI
(5'-tta tgg gaa ttc ctg gcc aag cct t-3') and BSD-R-PstI (5'-agt
tat ctg cag tca tta gcc ctc cca cac ata-3'). The resulting PCR
fragment was subcloned between the EcoRI and PstI sites
present in the mini-exon sequence. The myc tag sequence
was then replaced with EGFP. To do this, a PCR was per-
formed using pEGFP-C1 (Clontech) as a template and two
primers PstI/loxP/EGFP-F (5'-aac tgc aga taa ctt cgt ata atg
tat gct ata cga agt tat ggg tga gca agg gcg agg agc-3') and
XhoI/5'SS/EGFP-R (5'-cgg ctc gag cga gat cta ctt acc ttc ttg
tac agc tcg tcc atg cc-3'). The resulting PCR fragment was
subcloned between the PstI and XhoI sites replacing the
myc tag sequence. The mini-exon sequence was released
and subcloned into the 3' LTR of the pNL-neo vector [24]
between the EcoRV site and an XbaI site placed 28 nucle-
otides upstream of the R region [35] to generate pNL-5.1.
Dr. Alexander Chestkov provided the Cre recombinase-
encoding pNL-Cre plasmid. A Cre recombinase-encoding
fragment preceded by the CMV-IE promoter was derived
from pBS185 (Life Technologies). The VSV-G envelope-
encoding pLTR-G plasmid [23] and the pCD/NL-BH*∆∆∆
helper plasmid [36] were described before. All plasmid
sequences are available on-line http://www.med
school.lsuhsc.edu/reiser/.
Cell culture
Human embryonic kidney 293T cells [37] and HOS cells
(ATCC, CRL-1543) were maintained in Dulbecco's modi-
fied Eagle's medium (DMEM, Gibco) supplemented with
10 mM HEPES, 10% heat inactivated FBS (HyClone), 2.5
mM L-glutamine, 100 units/ml penicillin, and 100 µg/ml
streptomycin.
Virus production
Vector particles were produced in 293T cells by transient
co-transfection involving a three-plasmid expression sys-
tem [24]. Briefly, 293T cells were plated onto 150 mm
plates in 25 ml of medium (8 × 106 cells per plate) and 24
h later, pNL-5.1 vector plasmid DNA (21 µg), pCD/NL-
BH* ∆∆∆ helper plasmid DNA (14 µg), and pLTR-G DNA
(7 µg) were added. Transfection by calcium phosphate in
the presence of 25 µM chloroquine was carried out for 12–
15 h. The medium was replaced and virus particles
released into the medium were harvested 60–65 h after
transfection. Vector particles were concentrated by ultra-
centrifugation as described [38]. Vector titers were deter-
mined by real-time PCR as described [36].
Transduction of cells and clone selection
HOS cells (1 × 105) were plated on 100 mm plates. 24 h
later, NL-5.1 virus was added in medium containing 8 µg/
ml of polybrene (Sigma). A multiplicity of infection
(MOI) of 10 was used. Selection of BSD resistance colo-
nies was carried on in medium containing 5 µg/ml of blas-
ticidin (Invitrogen) for two weeks. Colonies were picked,
expanded in 6-well plates and transduced with NL-Cre
virus (MOI = 10). Transduction was followed by FACS
analysis using a Becton-Dickinson FACSCalibur.
Analysis of tagged sequences
Total RNA was isolated using the Trizol reagent (Invitro-
gen) according to the manufacturer's protocol. 5' and 3'
RACE was performed with the GeneRacer Kit (Invitrogen)
according to the manufacturer's protocol. The 3' and 5'
RACE products were run on a 1% agarose gel and the
bands sequenced on a 3100 Genetic Analyzer (AppliedBMC Genomics 2005, 6:113 http://www.biomedcentral.com/1471-2164/6/113
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Biosystems) using EGFP-specific primers. The sequences
obtained were subsequently analyzed by BLAST.
Confocal analysis of cell clones
Cells (5 × 104) were plated onto cover slips in six well
plates. After 24 h, the cells were washed twice with PBS,
dried and mounted with ProLong Antifade supplied by
Molecular Probes. Images were taken on a Nikon TE300
inverted microscope (confocal analysis) using the BioRad
Radiance 2000 Laser Scanning Confocal System or a Leica
DMRXA microscope and analyzed with Slidebook soft-
ware 4.0 from Intelligent Imaging Innovations (deconvo-
lution analysis).
Western blot analysis
Nuclear extracts were prepared by resuspending cell pel-
lets in lysis buffer (10 mM HEPES, pH 7.9, 10 mM KCl,
0.1 mM EDTA, 1.5 mM MgCl2, 0.2% v/v Nonidet P-40, 1
mM PMSF) and incubating for 5 min on ice. After centrif-
ugation at 6,000 rpm, pellets were resuspended in extrac-
tion buffer (20 mM HEPES, pH 7.9, 420 mM NaCl, 0.1
mM EDTA, 1.5 mM MgCl2, 25% v/v glycerol, 1 mM DTT,
0.05 mM PMSF), incubated on ice for 15 min and the
extracts centrifuged at 14,000 rpm for 15 min. Proteins
were separated by PAGE using 4–12% NuPAGE Bis-Tris
gels (Invitrogen). After electrophoresis, proteins were
transferred to a Immobilon-P membrane (Millipore). The
membrane was blocked with PBS containing 3% BSA for
2 h at room temperature. Probing was done using rabbit
anti-GFP antibody (A-11122, Molecular Probes) diluted
1:200 in PBS containing 3% BSA for 1 h at room temper-
ature followed by alkaline phosphate-conjugated goat
anti-rabbit IgG (Bio-Rad) diluted 1:2000 in PBS. The blot
was developed using BCIP/NBT (Sigma-Aldrich).
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